Paytm board appoints Pallavi Shroff as independent director
New Delhi: Paytm on Monday said Pallavi Shroff, managing partner at law firm Shardul Amarchand Mangaldas, has joined the board of directors at One97 Communications Ltd, the holding company of Paytm and e-commerce firm Paytm Mall.
She joins as an independent director and is the seventh appointee to Paytm’s board.
Renowned for its corporate law practice, Shardul Amarchand Mangaldas was formed in 2015 from a split at Amarchand & Mangaldas & Suresh A Shroff & Co., one of India’s oldest law firms.
Shroff has been practising law for over 34 years and has represented several private and public corporations in matters related to energy, infrastructure, natural resources, mergers and acquisitions, legislation and policy.
“Mrs. Shroff is one of the most distinguished leaders of the legal and corporate fraternity in India. We are delighted to welcome her to our board. We are building our financial services business, and aim to provide access to lending, insurance and wealth management solutions to a large, under-served population. Her experience will be key to the next phase of our growth plans,” Paytm founder and chief executive officer Vijay Shekhar Sharma said.
Shroff is presently on the board of directors of firms including Maruti Suzuki India Ltd, Apollo Tyres, Trident Group and Juniper Hotels Ltd. On joining Paytm, Shroff said: “I look forward to serving on their board, and guiding them on matters related to governance law and regulations.”
Paytm’s board of directors includes Kabir Misra, managing partner at SoftBank Capital, Joe Tsai, vice-chairman at Alibaba Group Holding Ltd, former Google executive Amit Singhal, Mark Schwartz, vice-chairman at Goldman Sachs Group, Ravi Adusumalli of SAIF Partners and Eric Jing, CEO of Ant Financial.
- Speeding up plans to cut emissions may save 153 million lives, says study
- Can hashgraph unseat blockchain as the favoured tech for cryptocurrencies?
- FDA-like agency needed for agriculture: commerce ministry
- Raju Shetti offers support to Congress over farmers’ issues
- Pharma firms under scanner for selling drugs without safety trials